ClinVar Miner

Submissions for variant NM_206933.3(USH2A):c.10667G>A (p.Gly3556Glu) (rs397517968)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000041675 SCV000065371 uncertain significance not specified 2016-09-15 criteria provided, single submitter clinical testing The p.Gly3556Glu variant in USH2A has not been reported in any individual with h earing loss in any other families or in large population studies. The Glycine (G ly) at position 3556 is not conserved in mammals or evolutionary distant species , and 2 mammals (black flying fox and megabat) carry a glutamic acid (Glu), rais ing the possibility that such a change at this position may be tolerated. Additi onal computational prediction tools suggest that this variant may impact the pro tein, though this information is not predictive enough to determine pathogenicit y. In summary, the clinical significance of the p.Gly3556Glu variant is uncertai n.
Counsyl RCV000671427 SCV000796402 uncertain significance Usher syndrome, type 2A; Retinitis pigmentosa 39 2017-12-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.